Target Health Blog

Blood Markers Identify Risk for Complications after Mild TBI

June 8, 2020


According to a study published in Neurology (27 May 2020), molecules released into the blood following mild traumatic brain injury (TBI) may be indicators of neuronal damage associated with conditions such as post-traumatic stress disorder (PTSD) and depression. This study included military veterans and servicemembers who were enrolled in the Chronic Effects of Neurotrauma Consortium (CENC) multicenter observational study of the long-term effects of mild TBI.

The study analyzed blood samples from former military personnel who had experienced one to two TBIs, more than two TBIs, or no TBIs, and screened for molecules released directly into the blood by cells of damaged tissue or inside vesicles called exosomes, which are bubble-like structures that contain a representative sample of cellular molecules. Results showed a significant correlation between multiple mild TBIs across the lifespan and higher levels of neurofilament light (NfL), a structural protein found inside neurons, and molecules involved in inflammation, such as tumor necrosis factor-alpha (TNF-alpha) and interleukin 6 (IL-6).

Further analysis revealed associations between increases in plasma and exosome levels of NfL, length of time since the last TBI, multiple TBIs, and increased severity of neurological and behavioral symptoms. These findings provide insights into potential mechanisms of TBI-associated neuroinflammatory and neurodegenerative processes correlated with persistent molecular effects of neuronal damage.

Source: NIH

Contact Target Health

Reach out today and let us know how we can help you!
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form